Inherited neurodegenerative disorder
MONDO:0024237An inherited disorder characterized by progressive degeneration and atrophy of the nervous system.
Also known as: genetic neurodegenerative disease, hereditary neurodegenerative disease, hereditary neurodegenerative disorder
808 clinical trials for this condition and its sub-types, 11 tagged with Inherited neurodegenerative disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Inherited neurodegenerative disorder
-
Frontotemporal dementia 132 trials · 178 incl. sub-types
4 sub-types
- GRN-related frontotemporal lobar degeneration with Tdp43 inclusions 6 trials · 47 incl. sub-types Sub-types →
- Behavioral variant of frontotemporal dementia 22 trials · 42 incl. sub-types Sub-types →
- Pick disease 35 trials
- Inclusion body myopathy with Paget disease of bone and frontotemporal dementia 1 trial · 3 incl. sub-types Sub-types →
-
Hereditary motor neuron disease 1 trial · 169 incl. sub-types
9 sub-types
- Spinal muscular atrophy 107 trials · 117 incl. sub-types Sub-types →
- Familial amyotrophic lateral sclerosis 2 trials · 29 incl. sub-types Sub-types →
- Lateral sclerosis 24 trials Sub-types →
- Riboflavin transporter deficiency 1 trial · 6 incl. sub-types Sub-types →
- Distal hereditary motor neuropathy 0 trials · 4 incl. sub-types Sub-types →
- ALS2-related motor neuron disease 0 trials Sub-types →
- Motor neuron disease with dementia and ophthalmoplegia 0 trials
- Neurogenic scapuloperoneal syndrome, Kaeser type 0 trials
- Prenatal-onset spinal muscular atrophy with congenital bone fractures 0 trials Sub-types →
-
Hereditary cerebellar ataxia 0 trials · 116 incl. sub-types
5 sub-types
- Autosomal recessive cerebellar ataxia 0 trials · 72 incl. sub-types Sub-types →
- Autosomal dominant cerebellar ataxia 11 trials · 33 incl. sub-types Sub-types →
- Ataxia telangiectasia 11 trials Sub-types →
- X-linked cerebellar ataxia 0 trials Sub-types →
- Ataxia-pancytopenia syndrome 0 trials
-
Huntington disease and related disorders 0 trials · 91 incl. sub-types
2 sub-types
- Huntington disease 76 trials Sub-types →
- Huntington disease-like syndrome 0 trials · 17 incl. sub-types Sub-types →
-
Progressive supranuclear palsy 74 trials · 78 incl. sub-types
4 sub-types
- Supranuclear palsy, progressive, 1 5 trials
- Atypical progressive supranuclear palsy syndrome 1 trial · 4 incl. sub-types Sub-types →
- Supranuclear palsy, progressive, 2 0 trials
- Supranuclear palsy, progressive, 3 0 trials
-
Leukodystrophy 6 trials · 72 incl. sub-types
65 sub-types
- Adrenoleukodystrophy 19 trials · 20 incl. sub-types Sub-types →
- Metachromatic leukodystrophy 20 trials Sub-types →
- Krabbe disease 15 trials Sub-types →
- Aicardi-Goutieres syndrome 9 trials Sub-types →
- Pelizaeus-Merzbacher spectrum disorder 8 trials Sub-types →
- Peroxisome biogenesis disorder 4 trials · 8 incl. sub-types Sub-types →
- Leukoencephalopathy with vanishing white matter 7 trials Sub-types →
- Canavan disease 6 trials Sub-types →
- Cerebrotendinous xanthomatosis 6 trials
- Leukoencephalopathy, diffuse hereditary, with spheroids 1 6 trials
- Alexander disease 5 trials Sub-types →
- Sjogren-Larsson syndrome 3 trials
- Leukodystrophy, demyelinating, adult-onset 0 trials · 3 incl. sub-types Sub-types →
- Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome 3 trials
- POLR-related leukodystrophy 0 trials · 2 incl. sub-types Sub-types →
- Pelizaeus-Merzbacher-like disease 1 trial · 2 incl. sub-types Sub-types →
- Hypomyelinating leukodystrophy 5 2 trials
- Hypomyelinating leukodystrophy 6 2 trials
- Hypomyelination with brain stem and spinal cord involvement and leg spasticity 2 trials
- Megalencephalic leukoencephalopathy with subcortical cysts 2 trials Sub-types →
- Sterol carrier protein 2 deficiency 1 trial
- AARS1-related leukoencephalopathy 0 trials Sub-types →
- CADDS 0 trials
- Adult-onset progressive leukoencephalopathy-early-onset deafness 0 trials
- Alkaline ceramidase 3 deficiency 0 trials
- C11orf73-related autosomal recessive hypomyelinating leukodystrophy 0 trials
- Cystic leukoencephalopathy without megalencephaly 0 trials
- Dermatoleukodystrophy 0 trials
- Early-onset calcifying leukoencephalopathy-skeletal dysplasia 0 trials
- Episodic memory defect leukoencephalopathy 0 trials
- Hereditary spastic paraplegia 2 0 trials
- Hypomyelinating leukodystrophy 10 0 trials
- Hypomyelinating leukodystrophy 12 0 trials
- Hypomyelinating leukodystrophy 13 0 trials
- Hypomyelinating leukodystrophy 9 0 trials
- Leukodystrophy, adult-onset, autosomal dominant, without amyloid angiopathy 0 trials
- Leukodystrophy, childhood-onset, remitting 0 trials
- Leukodystrophy, hypomyelinating, 14 0 trials
- Leukodystrophy, hypomyelinating, 15 0 trials
- Leukodystrophy, hypomyelinating, 16 0 trials
- Leukodystrophy, hypomyelinating, 17 0 trials
- Leukodystrophy, hypomyelinating, 18 0 trials
- Leukodystrophy, hypomyelinating, 19, transient infantile 0 trials
- Leukodystrophy, hypomyelinating, 20 0 trials
- Leukodystrophy, hypomyelinating, 22 0 trials
- Leukodystrophy, hypomyelinating, 23, with ataxia, deafness, liver dysfunction, and dilated cardiomyopathy 0 trials
- Leukodystrophy, hypomyelinating, 24 0 trials
- Leukodystrophy, hypomyelinating, 25 0 trials
- Leukodystrophy, hypomyelinating, 26, with chondrodysplasia 0 trials
- Leukodystrophy, hypomyelinating, 28 0 trials
- Leukoencephalopathy with bilateral anterior temporal lobe cysts 0 trials
- Leukoencephalopathy with mild cerebellar ataxia and white matter edema 0 trials
- Leukoencephalopathy without lacunae, adult-onset 0 trials
- Leukoencephalopathy, porphyria-related 0 trials
- Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome 0 trials
- Multiple mitochondrial dysfunctions syndrome 4 0 trials
- Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination 0 trials
- Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy 0 trials
- Polycystic lipomembranous osteodysplasia with sclerosing leukoencephaly 0 trials Sub-types →
- Progressive cavitating leukoencephalopathy 0 trials
- Progressive encephalopathy with leukodystrophy due to DECR deficiency 0 trials
- Ravine syndrome 0 trials
- Ribose-5-P isomerase deficiency 0 trials
- Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy 0 trials
- Unknown leukodystrophy 0 trials
-
Familial Alzheimer disease 13 trials · 55 incl. sub-types
2 sub-types
- Early-onset autosomal dominant Alzheimer disease 31 trials · 37 incl. sub-types Sub-types →
- Alzheimer disease 2 11 trials
-
Hereditary spastic paraplegia 27 trials · 33 incl. sub-types
45 sub-types
- Complex hereditary spastic paraplegia 1 trial · 7 incl. sub-types Sub-types →
- Hereditary spastic paraplegia 50 3 trials
- Hereditary spastic paraplegia 3A 2 trials
- Hereditary spastic paraplegia 4 2 trials
- Hereditary spastic paraplegia 5A 2 trials
- Hereditary spastic paraplegia 47 1 trial
- Hereditary spastic paraplegia 51 1 trial
- Hereditary spastic paraplegia 52 1 trial
- Hereditary spastic paraplegia 7 1 trial
- ADAR-related hereditary spastic paraplegia 0 trials
- Charcot-Marie-Tooth disease type 5 0 trials
- IFIH1-related hereditary spastic paraplegia 0 trials
- RNASEH2B-related hereditary spastic paraplegia 0 trials
- Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome 0 trials
- Hereditary spastic paraplegia 10 0 trials
- Hereditary spastic paraplegia 13 0 trials
- Hereditary spastic paraplegia 14 0 trials
- Hereditary spastic paraplegia 16 0 trials
- Hereditary spastic paraplegia 2 0 trials
- Hereditary spastic paraplegia 30 0 trials Sub-types →
- Hereditary spastic paraplegia 31 0 trials
- Hereditary spastic paraplegia 33 0 trials
- Hereditary spastic paraplegia 35 0 trials
- Hereditary spastic paraplegia 48 0 trials
- Hereditary spastic paraplegia 56 0 trials
- Hereditary spastic paraplegia 6 0 trials
- Hereditary spastic paraplegia 77 0 trials
- Macrocephaly-spastic paraplegia-dysmorphism syndrome 0 trials
- Mast syndrome 0 trials
- Pure hereditary spastic paraplegia 0 trials Sub-types →
- Pure or complex hereditary spastic paraplegia 0 trials
- Spastic paraplegia 72b, autosomal recessive 0 trials
- Spastic paraplegia 79A, autosomal dominant, with ataxia 0 trials
- Spastic paraplegia 80, autosomal dominant 0 trials
- Spastic paraplegia 81, autosomal recessive 0 trials
- Spastic paraplegia 82, autosomal recessive 0 trials
- Spastic paraplegia 83, autosomal recessive 0 trials
- Spastic paraplegia 87, autosomal recessive 0 trials
- Spastic paraplegia 88, autosomal dominant 0 trials
- Spastic paraplegia 89, autosomal recessive 0 trials
- Spastic paraplegia 90A, autosomal dominant 0 trials
- Spastic paraplegia 90B, autosomal recessive 0 trials
- Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia 0 trials
- Spastic paraplegia 92, autosomal recessive 0 trials
- Spastic paraplegia 93, autosomal recessive 0 trials
-
Hereditary optic atrophy 6 trials · 23 incl. sub-types
15 sub-types
- Leber hereditary optic neuropathy 18 trials Sub-types →
- Autosomal dominant optic atrophy 6 trials Sub-types →
- Optic atrophy 6 1 trial
- ACO2-related optic atrophy with or without extraocular features 0 trials Sub-types →
- Autosomal recessive optic atrophy, OPA7 type 0 trials
- Optic atrophy 10 with or without ataxia, intellectual disability, and seizures 0 trials
- Optic atrophy 11 0 trials
- Optic atrophy 12 0 trials
- Optic atrophy 13 with retinal and foveal abnormalities 0 trials
- Optic atrophy 14 0 trials
- Optic atrophy 15 0 trials
- Optic atrophy 16 0 trials
- Optic atrophy 2 0 trials
- Optic atrophy 4 0 trials
- Osteogenesis imperfecta-retinopathy-seizures-intellectual disability syndrome 0 trials
-
Neuronal ceroid lipofuscinosis 6 trials · 23 incl. sub-types
14 sub-types
- Neuronal ceroid lipofuscinosis 3 12 trials Sub-types →
- Neuronal ceroid lipofuscinosis 2 8 trials Sub-types →
- Juvenile neuronal ceroid lipofuscinosis 6 trials Sub-types →
- Ceroid lipofuscinosis, neuronal, 6A 4 trials Sub-types →
- Neuronal ceroid lipofuscinosis 7 2 trials
- Neuronal ceroid lipofuscinosis 8 1 trial · 2 incl. sub-types Sub-types →
- Neuronal ceroid lipofuscinosis 1 1 trial Sub-types →
- Neuronal ceroid lipofuscinosis 10 1 trial Sub-types →
- Neuronal ceroid lipofuscinosis 5 1 trial Sub-types →
- Adult neuronal ceroid lipofuscinosis 0 trials Sub-types →
- Ceroid lipofuscinosis, neuronal, 6B (Kufs type) 0 trials
- Congenital neuronal ceroid lipofuscinosis 0 trials
- Infantile neuronal ceroid lipofuscinosis 0 trials Sub-types →
- Progressive myoclonic epilepsy type 3 0 trials
-
Corticobasal syndrome 20 trials
-
Kennedy disease 19 trials
-
GM2 gangliosidosis 14 trials · 19 incl. sub-types
3 sub-types
- Sandhoff disease 13 trials Sub-types →
- Tay-Sachs disease 13 trials Sub-types →
- Tay-Sachs disease AB variant 0 trials
-
Frontotemporal dementia with motor neuron disease 14 trials · 19 incl. sub-types
7 sub-types
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 1 5 trials
- Amyotrophic lateral sclerosis type 10 3 trials
- Amyotrophic lateral sclerosis type 6 1 trial
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 0 trials
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 0 trials
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 0 trials
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 0 trials
-
Posterior cortical atrophy 12 trials
-
Chediak-Higashi syndrome 9 trials
-
Neurodegeneration with brain iron accumulation 1 trial · 8 incl. sub-types
14 sub-types
- Neurodegeneration with brain iron accumulation 5 4 trials
- Pantothenate kinase-associated neurodegeneration 4 trials Sub-types →
- PLA2G6-associated neurodegeneration 1 trial Sub-types →
- Kufor-Rakeb syndrome 0 trials Sub-types →
- Woodhouse-Sakati syndrome 0 trials
- Aceruloplasminemia 0 trials
- Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome 0 trials
- Fatty acid hydroxylase-associated neurodegeneration 0 trials
- Neurodegeneration with brain iron accumulation 4 0 trials
- Neurodegeneration with brain iron accumulation 6 0 trials
- Neurodegeneration with brain iron accumulation 7 0 trials
- Neurodegeneration with brain iron accumulation 8 0 trials
- Neurodegeneration with brain iron accumulation 9 0 trials
- Neuroferritinopathy 0 trials
-
Inherited Creutzfeldt-Jakob disease 5 trials
-
APP-related brain and vascular amyloidosis 0 trials · 5 incl. sub-types
2 sub-types
- Alzheimer disease type 1 4 trials
- Cerebral amyloid angiopathy, APP-related 0 trials · 1 incl. sub-types Sub-types →
-
Frontotemporal dementia and/or amyotrophic lateral sclerosis 0 trials · 5 incl. sub-types
8 sub-types
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 1 5 trials
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 0 trials
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 0 trials
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 0 trials
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 5 0 trials
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 0 trials
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 0 trials
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 8 0 trials
-
TUBB4A-related neurologic disorder 4 trials
1 sub-type
- Hypomyelinating leukodystrophy 6 2 trials
-
Fatal familial insomnia 4 trials
-
Alzheimer disease 17 1 trial
-
Alzheimer disease 18 1 trial
-
3 sub-types
-
DCTN1-related neurodegeneration 0 trials
2 sub-types
- Perry syndrome 0 trials
- Neuronopathy, distal hereditary motor, type 7B 0 trials
-
Huntington disease-like 1 0 trials
-
Huntington disease-like 2 0 trials
-
ITM2B amyloidosis 0 trials
2 sub-types
- ABri amyloidosis 0 trials
- ADan amyloidosis 0 trials
-
PEHO syndrome 0 trials
-
Angioid streaks of choroid 0 trials
-
Attenuated Chédiak-Higashi syndrome 0 trials
-
Autosomal recessive cerebral atrophy 0 trials
-
Boylan dew greco syndrome 0 trials
-
1 sub-type
-
Deafness dystonia syndrome 0 trials
-
2 sub-types
-
Ferro-cerebro-cutaneous syndrome 0 trials
-
Myoclonic cerebellar dyssynergia 0 trials
-
Striatonigral degeneration 0 trials
3 sub-types
Most studied deeper sub-types
-
Can Gene-Modified stem cells stop a devastating brain disease?
Cure Not yet recruitingThis trial tests a gene therapy for metachromatic leukodystrophy (MLD), a rare inherited disease that damages the nervous system. Researchers take a patient's own blood stem cells, add a corrected gene, and infuse them back. The goal is to see if this approach is safe and can slo…
Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Cure
Last updated Sep 03, 2026 00:00 UTC
-
Fasting-Mimicking diet tested to protect aging brains
Disease control Not yet recruitingThis study tests whether a special low-calorie, plant-based diet taken for 5 days each month can safely improve blood flow to the brain in middle-aged adults who carry the APOE4 gene, which raises Alzheimer's risk. Forty participants aged 45-65 will be randomly assigned to either…
Phase 1/2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Experimental gene therapy aims to halt fatal brain disease in children
Disease control Not yet recruitingThis trial tests a gene therapy for X-linked adrenoleukodystrophy (X-ALD), a rare genetic disease that damages the brain. The therapy uses a modified virus to deliver a working copy of the faulty gene directly into the spinal fluid and bloodstream. Up to 30 patients aged 1 year a…
Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Gene therapy aims to halt fatal brain disease in children
Disease control Not yet recruitingThis trial tests a gene therapy for metachromatic leukodystrophy (MLD), a rare and life-threatening genetic disorder that damages the nervous system. The treatment uses a lentivirus to deliver a working copy of the ARSA gene directly into the spinal fluid and bloodstream. Up to 1…
Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can targeted brain zaps ease movement problems in a rare ataxia?
Disease control Not yet recruitingThis trial tests a non-invasive brain stimulation technique called transcranial temporal interference stimulation (tTIS) in people with spinocerebellar ataxia type 3, a genetic condition that affects coordination and balance. The stimulation targets a deep brain region involved i…
Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can gene therapy help babies with SMA reach milestones? a Real-World review
Disease control Not yet recruitingThis study looks back at medical records of children with spinal muscular atrophy (SMA) type 1 who received a one-time gene therapy called onasemnogene abeparvovec (Zolgensma). Researchers want to see if treated infants can sit independently for 30 seconds or more within a year. …
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can diet and vitamin c supercharge rectal cancer treatment?
Disease control Not yet recruitingThis phase 2 trial is investigating whether adding a ketogenic diet and/or high-dose intravenous vitamin C to standard chemoradiotherapy and immunotherapy can improve outcomes for patients with locally advanced rectal cancer that is mismatch repair proficient (pMMR/MSS). The stud…
Phase 2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Experimental drug aims to halt rare neurological decline
Disease control Not yet recruitingThis Phase 3 trial tests whether vatiquinone can slow the progression of Friedreich's ataxia, a rare genetic disorder that damages the nervous system and impairs movement. About 120 adults with moderate symptoms will take the drug for 24 months. Researchers will measure changes i…
Phase 3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can singing and constraint therapy rebuild speech after stroke?
Disease control Not yet recruitingThis trial investigates whether combining two behavioral therapies can help people with non-fluent aphasia—a condition where stroke damages the brain's language centers, making speech difficult. The approach uses Melodic Intonation Therapy (MIT), which uses singing-like intonatio…
Sponsor: Universidad de Granada • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can brain stimulation tame ataxia?
Disease control Not yet recruitingThis trial tests whether deep brain stimulation (DBS) targeting the cerebellum is safe and feasible for people with spinocerebellar ataxia types 1 and 3, a group of inherited disorders that cause progressive problems with movement and coordination. The study will enroll 12 adults…
Sponsor: Gordon H. Baltuch • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a repurposed drug slow rare childhood brain diseases?
Disease control Not yet recruitingThis phase 2 trial is testing an oral drug called PLX-200 (gemfibrozil) in children aged 2 to 15 with certain lysosomal storage disorders (LSDs), including CLN2, CLN3, Sandhoff disease, and Krabbe disease. The study aims to see if the drug is safe, tolerable, and may slow the pro…
Phase 2 • Sponsor: Polaryx Therapeutics, Inc. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Nasal spray of stem cell 'Messages' could slow rare brain disease
Disease control Not yet recruitingThis study tests a new nasal spray treatment for frontotemporal dementia (FTD), a brain disease that changes personality and language. The spray contains tiny particles from umbilical cord stem cells that may protect brain cells and reduce harmful protein buildup. About 33 adults…
Phase 1/2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a simple gel boost gum healing in diabetes?
Disease control Not yet recruitingThis study tests whether adding hyaluronic acid gel to standard deep cleaning (scaling and root planing) improves gum healing in people with both diabetes and advanced gum disease. Twenty-three participants will receive the standard cleaning on all teeth, and then two gum pockets…
Sponsor: Marmara University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Sound waves may help clear Alzheimer's brain clogs
Disease control Not yet recruitingThis early-stage study tests whether a focused ultrasound can safely and temporarily open the brain's protective barrier in people with early Alzheimer's disease. The goal is to see if this helps clear harmful amyloid and tau proteins that build up in the brain. Six participants …
Phase 1 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Experimental gene therapy aims to halt rare childhood brain disease
Disease control Not yet recruitingThis early-phase trial tests a gene therapy for children with CLN6 Batten disease, a rare and fatal brain disorder. Twelve children will receive a single injection of the therapy into the fluid around the spinal cord. Researchers will check if it is safe and if it can slow the di…
Phase 1/2 • Sponsor: The Charlotte and Gwenyth Gray Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could Low-Dose radiation slow Alzheimer's? new trial aims to find out
Disease control Not yet recruitingThis study tests whether low-dose radiation to the whole brain can slow down Alzheimer's disease in people with early-onset symptoms. Fifty participants will be randomly assigned to receive either the radiation treatment or a sham procedure. Researchers will track changes in memo…
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo therapy aims to spare organs in High-Risk rectal cancer
Disease control Not yet recruitingThis phase 3 trial tests whether short-course radiation followed by chemotherapy and an immunotherapy drug (serplulimab) works better than standard long-course chemoradiation for high-risk locally advanced rectal cancer. 612 patients will be randomly assigned to one of the two tr…
Phase 3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could stem cells help people with spinocerebellar ataxia? new trial aims to find out
Disease control Not yet recruitingThis Phase 2 trial tests whether umbilical cord stem cells can safely improve movement and coordination in people with spinocerebellar ataxia (types 1, 2, 3, and 6). Forty-five participants will receive the cells through an IV and a spinal injection. The main goal is to see if sy…
Phase 2 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could stem cells help people with spinocerebellar ataxia?
Disease control Not yet recruitingThis early-stage trial tests whether stem cells and their exosomes (tiny particles that help cells communicate) can safely improve movement in people with spinocerebellar ataxia, a condition that affects coordination and balance. Ninety participants will receive the treatment thr…
Phase 1/2 • Sponsor: Biocells Medical • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New gene therapy hopes to fix fatal brain diseases
Disease control Not yet recruitingThis study tests a new gene therapy for GM2 gangliosidosis, which includes Tay-Sachs and Sandhoff diseases. Researchers will take blood cells from 6 patients, fix the genetic defect in the lab, and then see if these cells can help brain cells work better. The goal is to show the …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Could vitamin B3 save sight in rare genetic blindness?
Disease control Not yet recruitingThis early study tests whether high-dose vitamin B3 (nicotinamide) can help preserve or improve vision in people with Leber's hereditary optic neuropathy (LHON), a rare genetic disease that causes sudden vision loss. Researchers will give 13 participants 2 grams of vitamin B3 dai…
Phase 1 • Sponsor: University Hospital, Angers • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Experimental antibody aims to repair brain connections in rare dementia
Disease control Not yet recruitingThis study tests a new drug called NS101 in 15 people with semantic variant primary progressive aphasia (svPPA), a rare type of frontotemporal dementia that affects language and memory. The drug is an antibody designed to help repair connections between brain cells. The main goal…
Phase 2 • Sponsor: Hee-Jin Kim • Aim: Disease control
Last updated Jun 26, 2026 14:05 UTC
-
AI listens for dementia: new speech test could speed up diagnosis
Diagnosis Not yet recruitingThis observational study will enroll 440 Danish-speaking adults over 50 to see if an artificial intelligence model can detect dementia and mild cognitive impairment from speech recordings. Participants will complete standard cognitive tests and describe a picture while being reco…
Sponsor: Zealand University Hospital • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
A 5-Day genetic test could slash time to transplant for children with rare immune disease
Diagnosis Not yet recruitingThis trial tests whether a new ultra-rapid genetic test, using third-generation sequencing, can diagnose familial lymphohistiocytosis (FHL) in children within 5 days instead of the usual 6-8 weeks. FHL is a rare, life-threatening genetic condition where the immune system attacks …
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC
-
New brain test aims to unravel language confusion in dementia
Diagnosis Not yet recruitingThis study is testing a new cognitive assessment called the ExéSem battery, designed to help doctors tell the difference between language problems caused by memory loss versus those caused by thinking difficulties. Researchers will enroll 140 people, including those with Alzheime…
Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
New brain scan tracer could spot Alzheimer's and Parkinson's earlier
Diagnosis Not yet recruitingThis early-phase trial will test a new radioactive tracer called 18F-FCOB04 in 40 people with neurodegenerative diseases like Alzheimer's or Parkinson's. The tracer targets a brain protein called MAO-B and is used with PET scans to see if it can help diagnose these conditions. Th…
Early phase 1 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
New spinal fluid test aims to solve dementia misdiagnosis puzzle
Diagnosis Not yet recruitingThis study will test whether measuring a specific abnormal protein (alpha-synuclein) in spinal fluid can reliably distinguish dementia with Lewy bodies (DLB) from Alzheimer's disease. Researchers will collect samples and perform cognitive tests on 286 older adults with suspected …
Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Jun 26, 2026 16:49 UTC
-
Robot leg training tuned to each child may build stronger knees in SMA
Symptom relief Not yet recruitingResearchers are testing a portable knee-training robot in children aged 6 to 12 with spinal muscular atrophy. Each child trains one leg with a flexible, individually tuned stiffness setting and the other leg with a rigid setting for up to 8 weeks. The trial compares how much knee…
Sponsor: Peking University Third Hospital • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Zapping a brain region may curb impulsivity in PSP
Symptom relief Not yet recruitingProgressive supranuclear palsy (PSP) causes problems with movement, thinking, and behavior, including impulsivity that can lead to falls. Researchers are testing a non-invasive brain stimulation technique called transcranial direct current stimulation (tDCS) aimed at the right in…
Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Can a common antipsychotic keep cannabis users out of the ER?
Symptom relief Not yet recruitingThis trial tests whether giving patients a prescription for haloperidol to use as needed at home can help control symptoms of cannabinoid hyperemesis syndrome — a condition marked by severe nausea, vomiting, and abdominal pain from heavy cannabis use. The goal is to see if having…
Early phase 1 • Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Can sound waves soothe Dementia's emotional turmoil?
Symptom relief Not yet recruitingThis early study tests whether a single session of focused ultrasound—using sound waves to gently stimulate a specific brain region—can safely reduce emotional symptoms like agitation, irritability, and anxiety in people with mild dementia. Fifteen participants aged 45 to 80 with…
Sponsor: West Virginia University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New therapy aims to ease grief after miscarriage or stillbirth
Symptom relief Not yet recruitingThis pilot study tests a 4-week program based on acceptance and commitment therapy (ACT) for women who have experienced a miscarriage, stillbirth, or newborn death within the past year. The program includes six sessions plus a booster, combining in-person and video meetings. Rese…
Sponsor: Second Xiangya Hospital of Central South University • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Exercise and drug combo may fight fatigue in rare disease
Symptom relief Not yet recruitingThis study looks at whether doing aerobic exercise at home, with or without the drug omaveloxolone, can safely improve fatigue and heart-lung fitness in people with Friedreich's ataxia. About 30 adults with the condition will take part. The goal is to see if the combination helps…
Sponsor: Scott Barbuto • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Can a support group boost confidence for parents of kids with DMD or SMA?
Symptom relief Not yet recruitingThis study tests whether a multicomponent support group can improve the confidence (self-efficacy) of primary caregivers of children with Duchenne muscular dystrophy or spinal muscular atrophy in Pakistan. Thirty caregivers will join group sessions with doctors, therapists, and o…
Sponsor: Aga Khan University • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Can ancient chinese music therapy help stroke survivors speak again?
Symptom relief Not yet recruitingThis study tests whether a special type of speech training using five musical tones can help people with aphasia (trouble speaking) after a stroke. Researchers will enroll 120 adults who had a stroke and have non-fluent aphasia. Participants will receive either five-tone therapy …
Sponsor: Fujian University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Horse power: new therapy hopes to improve movement in SMA children
Symptom relief Not yet recruitingThis study tests whether a special type of horseback physiotherapy can improve movement, posture, breathing, and quality of life in children with spinal muscular atrophy (SMA). Twenty children aged 2 to 9 years will receive both the horse therapy and standard physiotherapy in ran…
Sponsor: Charles University, Czech Republic • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Robot suit aims to get kids with disabilities walking
Symptom relief Not yet recruitingThis study tests a robotic exoskeleton called CLINICAL EXPLORER in 60 children aged 2 to 17 with neurodevelopmental disorders like cerebral palsy. The device supports walking during 8 therapy sessions. Researchers will check if it is safe, easy to use, and helps improve movement …
Sponsor: MarsiBionics • Aim: Symptom relief
Last updated Jun 26, 2026 14:47 UTC
-
Walking memory tests may reveal early Parkinson's clues
Knowledge-focused Not yet recruitingResearchers are studying whether navigational memory fades before other spatial memory in people with Parkinson's disease and related conditions. The pilot includes 80 participants: those with mild or advanced Parkinson's, those with parkinsonism, and healthy volunteers. Particip…
Sponsor: IRCCS San Raffaele Roma • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can gene therapy zolgensma safely improve motor skills in SMA?
Knowledge-focused Not yet recruitingThis study follows 80 people with spinal muscular atrophy (SMA) in Japan who receive Zolgensma (onasemnogene abeparvovec) as an intrathecal injection. The goal is to track safety issues, such as liver problems or blood clotting abnormalities, and to measure changes in motor funct…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Wearable sensors aim to catch neurodegenerative decline in real time
Knowledge-focused Not yet recruitingThis observational study tests whether wearable sensors and digital health tools can reliably measure falls, movement, speech, and thinking skills in people with progressive supranuclear palsy, Parkinson's disease, or multiple system atrophy. Participants wear a pendant sensor an…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Video games and AI join the fight against a rare movement disorder
Knowledge-focused Not yet recruitingThis study is testing whether a new digital tool—using AI-powered video games and a single camera—can accurately measure movement problems in people with Friedreich ataxia, a rare inherited condition that affects balance and coordination. Participants play short movement-based co…
Sponsor: University of Exeter • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Could pomegranate supplements help heal the gut in Alcohol-Related liver disease?
Knowledge-focused Not yet recruitingThis study investigates how pomegranate dietary supplements influence gut bacteria and inflammation in people with alcohol use disorder and alcohol-related liver disease. Researchers will measure levels of beneficial gut metabolites called urolithins and inflammatory markers in b…
Sponsor: University of Louisville • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
School transitions put to the test for children with a rare muscle disease
Knowledge-focused Not yet recruitingThis study uses questionnaires and focus groups to understand the challenges children with spinal muscular atrophy (SMA) and their families face when moving between schools or starting a new educational stage. Researchers aim to identify barriers to inclusion and support, and to …
Sponsor: Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Could early markers unlock treatments for a rare childhood disease?
Knowledge-focused Not yet recruitingThis study follows babies and young children (up to age 5) who have a genetic diagnosis of ataxia telangiectasia (A-T), a rare disease that affects movement and immunity. Researchers use brain and lung scans, blood tests, and movement analysis to spot early signs of disease progr…
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Smart sensors could track brain disease at home
Knowledge-focused Not yet recruitingThis study will test whether wearable sensors can accurately monitor movement problems in people with progressive supranuclear palsy (PSP) and dementia with Lewy bodies (DLB). About 60 participants will wear small sensors on their chest, ankles, and wrists while doing simple task…
Sponsor: BioSensics • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New study explores how families cope with feeding and talking challenges in SMA type 1
Knowledge-focused Not yet recruitingThis study will interview 15 parents or guardians of children with spinal muscular atrophy type 1 to learn about their daily challenges with feeding and communication. Even though newer treatments have improved survival, their impact on swallowing and speech is not well understoo…
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to spot Parkinson's early with simple blood, urine, and stool tests
Knowledge-focused Not yet recruitingThis observational study will enroll 200 people—100 with Parkinson's disease, 50 with related conditions, and 50 healthy controls—to find molecular markers in blood, urine, and stool that can distinguish Parkinson's from atypical parkinsonism. Participants provide samples and und…
Sponsor: International Institute of Molecular and Cell Biology in Warsaw • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Smart sensors could revolutionize dementia monitoring at home
Knowledge-focused Not yet recruitingThis study will test if wearable sensors can effectively monitor symptoms and daily function in people with frontotemporal dementia (FTD). Sixty adults with FTD will wear pendant and wrist sensors for two weeks at a time, every six months over two years. The goal is to develop di…
Sponsor: BioSensics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Smart sensors could revolutionize how we track FTD symptoms
Knowledge-focused Not yet recruitingThis study tests whether wearable sensors and computerized voice and thinking tests can reliably track symptoms in people with frontotemporal dementia (FTD). Twenty participants will wear sensors and complete assessments at home over 12 months. The goal is to develop digital biom…
Sponsor: BioSensics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Hidden fracture risk in kids with SMA under spotlight
Knowledge-focused Not yet recruitingThis study looks at bone health in children with spinal muscular atrophy (SMA), a condition that causes muscle weakness. Researchers want to find out how common fractures are and whether newer SMA treatments affect bone strength. They will review medical records from about 550 ch…
Sponsor: Sheffield Children's NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Can a smart wearable track a rare brain disease at home?
Knowledge-focused Not yet recruitingThis study will test a wearable device called Syde® in 30 people with progressive supranuclear palsy (PSP-R). The device tracks movement and activity during daily life. Researchers want to see if patients find it easy to use and if the data matches standard clinic tests. The goal…
Sponsor: SYSNAV • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can a chatbot ease the burden on caregivers? new study aims to find out
Knowledge-focused Not yet recruitingThis study will see if an AI chatbot app is practical and acceptable for family caregivers of people with traumatic brain injury, dementia, or Huntington disease. About 60 caregivers will use the app for 8 weeks, focusing on physical and mental health. They will complete surveys …
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Radioactive pill tested in healthy men to map huntington Drug's path
Knowledge-focused Not yet recruitingThis early-stage study will give 8 healthy men a single radioactive dose of LPM3770164, a drug being developed for Huntington disease. Researchers will measure how much of the drug is recovered in urine and stool, and identify its breakdown products. The goal is to understand how…
Phase 1 • Sponsor: Luye Pharma Group Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Eye movements may reveal hidden memory problems in Huntington's
Knowledge-focused Not yet recruitingThis study looks at how Huntington's disease impacts autobiographical memory—the ability to recall personal experiences and imagine future events. Researchers will use eye-tracking and neuropsychological tests in 80 participants (patients and healthy controls) to find markers of …
Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Are these two eye diseases actually the same? new study aims to find out
Knowledge-focused Not yet recruitingThis study will look back at medical records of 45 people with either Wolfram syndrome or a related eye condition caused by changes in the WFS1 gene. Researchers want to see if these two conditions are truly different by comparing vision loss over time and other health problems. …
Sponsor: Hôpital Necker-Enfants Malades • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Smart sensors could revolutionize Huntington's monitoring
Knowledge-focused Not yet recruitingThis study aims to see if wearable sensors and digital health tools can accurately track symptoms of Huntington's disease over 12 months. About 75 adults with and without Huntington's will wear sensors on their wrist, ankle, and pendant to measure daily activity, and complete spe…
Sponsor: BioSensics • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
New study probes emotional toll of SMA screening on new parents
Knowledge-focused Not yet recruitingThis study looks at how parents feel after their newborn is screened for spinal muscular atrophy (SMA). Researchers will interview 36 parents in two French regions to understand their anxiety, stress, and support needs. The goal is to improve how screening results are shared and …
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC